Eli Lilly and Company: Hypoglycemia trials
The registry lists 10 Hypoglycemia studies with Eli Lilly and Company as lead sponsor. 0 are open to participants now and 9 have results posted.
Phase 1 4Phase 2 2Phase 3 3No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 DiabetesCompletedNCT05262387Phase 1Results posted
- A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 DiabetesCompletedNCT04992312Phase 1Results posted
- A Study of Tirzepatide in Participants With Type 2 Diabetes MellitusCompletedNCT04050553Phase 1Results posted
- A Study of Nasal Glucagon in Participants With Type 1 Diabetes MellitusCompletedNCT03339453Phase 1Results posted
- Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and AdolescentsCompletedNCT02402933Phase 3Results posted
- Clinical Usability of Intranasal Glucagon in Treatment of HypoglycemiaCompletedNCT02171130Phase 3Results posted
- Evaluate the Immunogenicity of a Novel Glucagon FormulationCompletedNCT01959334Phase 3Results posted
- Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced HypoglycemiaCompletedNCT01556594Phase 2Results posted
- An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 DiabetesCompletedNCT01400971Results posted
- A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal InsulinActive, not recruitingNCT07215312Phase 2